Jason T Romancik (Jason Romancik)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 16

Top Topics

Reduced Graphene Oxide

Monoclonal Antibody

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Reem Karmali, Rushad Machhi, Narendranath Epperla, Geoffrey Shouse, Jason T Romancik, Tamara K Moyo, Vaishalee P Kenkre, Thomas A Ollila, Lindsey A Fitzgerald, Brian T Hess, Kevin A David, Ishan Roy, Joanna C Zurko, Sayan Mullick Chowdhury, Kaitlin Annunzio, Robert Ferdman, Rahul S Bhansali, Elyse I Harris, Jieqi Liu, Imran A Nizamuddin, Shuo Ma, Jonathan Moreira, Jane N Winter, Barbara Pro, Deborah M Stephens, Alexey V Danilov, Nirav N Shah, Jonathon B Cohen, Stefan K Barta, Pallawi Torka, Leo I Gordon
Impact of Race and Social Determinants of Health on Outcomes in Patients with Aggressive B-cell nHL Treated with CAR-T. Blood advances (2024)
Arushi Khurana, Raphael Mwangi, Loretta J Nastoupil, Patrick M Reagan, Umar Farooq, Jason T Romancik, Timothy McDonnell, Shaun Riska, Izidore S Lossos, Brad S Kahl, Peter Martin, Thomas E Witzig, James R Cerhan, Christopher R Flowers, Grzegorz S Nowakowski, Matthew John Maurer
Evaluating Lab-Based Eligibility Criteria by Race/Ethnicity in Clinical Trials of Diffuse Large B-Cell Lymphoma. Blood advances (2024)
Arushi Khurana, Raphael Mwangi, Loretta J Nastoupil, Patrick M Reagan, Umar Farooq, Jason T Romancik, Timothy J McDonnell, Shaun M Riska, Izidore S Lossos, Brad S Kahl, Peter Martin, Thomas E Witzig, James R Cerhan, Christopher R Flowers, Grzegorz S Nowakowski, Matthew John Maurer
Evaluating the impact of laboratory-based eligibility criteria by race/ethnicity in first-line clinical trials of DLBCL. Blood advances 8 (16) (2024)
Reem Karmali, Rushad Machhi, Narendranath Epperla, Geoffrey Shouse, Jason T Romancik, Tamara K Moyo, Vaishalee Kenkre, Thomas A Ollila, Lindsey Fitzgerald, Brian Hess, Kevin A David, Ishan Roy, Joanna C Zurko, Sayan Mullick Chowdhury, Kaitlin Annunzio, Robert Ferdman, Rahul S Bhansali, Elyse I Harris, Jieqi Liu, Imran Nizamuddin, Shuo Ma, Jonathan Moreira, Jane Winter, Barbara Pro, Deborah M Stephens, Alexey Danilov, Nirav N Shah, Jonathon B Cohen, Stefan K Barta, Pallawi Torka, Leo I Gordon
Impact of race and social determinants of health on outcomes in patients with aggressive B-cell NHL treated with CAR-T therapy. Blood advances 8 (10) (2024)
Megan Melody, Narendranath Epperla, Geoffrey Shouse, Jason T Romancik, Pamela Blair Allen, Tamara K Moyo, Vaishalee Kenkre, Thomas A Ollila, Lindsey Fitzgerald, Brian Hess, Kevin A David, Megan M Herr, Oluwatobi Odetola, Adam Yuh Lin, Jonathan Moreira, Shuo Ma, Jane N Winter, Ishan Roy, Deborah M Stephens, Alexey Danilov, Nirav N Shah, Stefan K Barta, Matthew Cortese, Jonathon B Cohen, Leo I Gordon, Reem Karmali
Subsequent malignant neoplasms in patients previously treated with anti-CD19 CAR T-cell therapy. Blood advances 8 (10) (2024)
Megan Melody, Narendranath Epperla, Geoffrey Shouse, Jason T Romancik, Pamela Blair Allen, Tamara K Moyo, Vaishalee Kenkre, Thomas A Ollila, Lindsey Fitzgerald, Brian Hess, Kevin A David, Megan M Herr, Oluwatobi Odetola, Adam Yuh Lin, Jonathan Moreira, Shuo Ma, Jane N Winter, Ishan Roy, Deborah M Stephens, Alexey Danilov, Nirav N Shah, Stefan K Barta, Matthew Cortese, Jonathon B Cohen, Leo I Gordon, Reem Karmali
Subsequent malignant neoplasms in patients previously treated with anti-CD19 CAR T-cell therapy. Blood advances 8 (10) (2024)
Reem Karmali, Rushad Machhi, Narendranath Epperla, Geoffrey Shouse, Jason T Romancik, Tamara K Moyo, Vaishalee Kenkre, Thomas A Ollila, Lindsey Fitzgerald, Brian Hess, Kevin A David, Ishan Roy, Joanna C Zurko, Sayan Mullick Chowdhury, Kaitlin Annunzio, Robert Ferdman, Rahul S Bhansali, Elyse I Harris, Jieqi Liu, Imran Nizamuddin, Shuo Ma, Jonathan Moreira, Jane Winter, Barbara Pro, Deborah M Stephens, Alexey Danilov, Nirav N Shah, Jonathon B Cohen, Stefan K Barta, Pallawi Torka, Leo I Gordon
Impact of race and social determinants of health on outcomes in patients with aggressive B-cell NHL treated with CAR-T therapy. Blood advances 8 (10) (2024)
Megan Melody, Narendranath Epperla, Geoffrey Shouse, Jason T Romancik, Pamela Blair Allen, Tamara K Moyo, Vaishalee Kenkre, Thomas A Ollila, Lindsey Fitzgerald, Brian Hess, Kevin A David, Megan M Herr, Oluwatobi Odetola, Adam Yuh Lin, Jonathan Moreira, Shuo Ma, Jane N Winter, Ishan Roy, Deborah M Stephens, Alexey Danilov, Nirav N Shah, Stefan K Barta, Matthew Cortese, Jonathon B Cohen, Leo I Gordon, Reem Karmali
Subsequent malignant neoplasms in patients previously treated with anti-CD19 CAR T-cell therapy. Blood advances 8 (10) (2024)
Reem Karmali, Rushad Machhi, Narendranath Epperla, Geoffrey Shouse, Jason T Romancik, Tamara K Moyo, Vaishalee Kenkre, Thomas A Ollila, Lindsey Fitzgerald, Brian Hess, Kevin A David, Ishan Roy, Joanna C Zurko, Sayan Mullick Chowdhury, Kaitlin Annunzio, Robert Ferdman, Rahul S Bhansali, Elyse I Harris, Jieqi Liu, Imran Nizamuddin, Shuo Ma, Jonathan Moreira, Jane Winter, Barbara Pro, Deborah M Stephens, Alexey Danilov, Nirav N Shah, Jonathon B Cohen, Stefan K Barta, Pallawi Torka, Leo I Gordon
Impact of race and social determinants of health on outcomes in patients with aggressive B-cell NHL treated with CAR-T therapy. Blood advances 8 (10) (2024)
Megan Melody, Narendranath Epperla, Geoffrey Shouse, Jason T Romancik, Pamela Blair Allen, Tamara K Moyo, Vaishalee Kenkre, Thomas A Ollila, Lindsey Fitzgerald, Brian Hess, Kevin A David, Megan M Herr, Oluwatobi Odetola, Adam Yuh Lin, Jonathan Moreira, Shuo Ma, Jane N Winter, Ishan Roy, Deborah M Stephens, Alexey Danilov, Nirav N Shah, Stefan K Barta, Matthew Cortese, Jonathon B Cohen, Leo I Gordon, Reem Karmali
Subsequent malignant neoplasms in patients previously treated with anti-CD19 CAR T-cell therapy. Blood advances 8 (10) (2024)
Megan Melody, Narendranath Epperla, Geoffrey Shouse, Jason T Romancik, Pamela Blair Allen, Tamara K Moyo, Vaishalee P Kenkre, Thomas A Ollila, Lindsey A Fitzgerald, Brian T Hess, Kevin A David, Megan M Herr, Oluwatobi Odetola, Adam Yuh Lin, Jonathan Moreira, Shuo Ma, Jane N Winter, Ishan Roy, Deborah M Stephens, Alexey V Danilov, Nirav N Shah, Stefan K Barta, Matthew J Cortese, Jonathon B Cohen, Leo I Gordon, Reem Karmali
Subsequent Malignant Neoplasms in Patients Previously Treated with Anti-CD19 CAR T-Cell Therapy. Blood advances (2024)
David A Qualls, Nicholas Lambert, Paolo F Caimi, Mwanasha H Merrill, Priyanka Pullarkat, Richard C Godby, David A Bond, Graham T Wehmeyer, Jason T Romancik, Behzad Amoozgar, Lori A Leslie, Loretta J Nastoupil, Jennifer L Crombie, Jeremy S Abramson, Arushi Khurana, Grzegorz S Nowakowski, Kami J Maddocks, Sarah C Rutherford, Brad S Kahl, Michelle Okwali, Michael J Buege, Venkatraman E Seshan, Connie Lee Batlevi, Gilles Andre Salles
Tafasitamab and lenalidomide in large B cell lymphoma: real-world outcomes in a multicenter retrospective study. Blood (2023)
Ajay Major, Jovian Yu, Navika Shukla, Yan Che, Theodore G Karrison, Rachel Treitman, Manali Kamdar, Bradley M Haverkos, James Godfrey, Melissa A Babcook, Timothy J Voorhees, Sophie Gabrielle Carlson, Daria Gaut, Caspian Oliai, Jason T Romancik, Allison M Winter, Brian T Hill, Radhika Bansal, Jose C Villasboas Bisneto, Imran A Nizamuddin, Reem Karmali, Lindsey A Fitzgerald, Deborah M Stephens, Priyanka A Pophali, Asaad Trabolsi, Jonathan H Schatz, Marie Hu, Veronika Bachanova, Michael Joseph Slade, Nathan Singh, Nausheen Ahmed, Joseph P McGuirk, Michael R Bishop, Peter A Riedell, Justin Kline
Efficacy of checkpoint inhibition after CAR-T failure in aggressive B-cell lymphomas: Outcomes from 15 U.S. institutions. Blood advances (2023)
Yazeed Sawalha, Subir Goyal, Jeffrey M Switchenko, Jason T Romancik, Manali Kamdar, Irl Brian Greenwell, Brian T Hess, Krista M Isaac, Craig A Portell, Alex V Mejia Garcia, Scott R Goldsmith, Natalie S Grover, Peter A Riedell, Reem Karmali, Madelyn Burkart, Michael J Buege, Othman S Akhtar, Pallawi Torka, Anita Kumar, Brian T Hill, Brad S Kahl, Jonathon B Cohen
A Multicenter Analysis of the Outcomes with Venetoclax in Patients with Relapsed Mantle Cell Lymphoma. Blood advances (2023)
Joanna C Zurko, Imran Nizamuddin, Narendranath Epperla, Kevin A David, Jonathon B Cohen, Tamara Moyo, Thomas A Ollila, Brian T Hess, Ishan Roy, Robert Ferdman, Jieqi Liu, Sayan Mullick Chowdhury, Jason T Romancik, Rahul S Bhansali, Elyse I Harris, Mckenzie Sorrell, Rebecca Masel, Adam S Kittai, Nathan Denlinger, Audrey M Sigmund, Lindsey A Fitzgerald, Carlos Galvez, Shuo Ma, Jane N Winter, Barbara Pro, Leo I Gordon, Alexey V Danilov, Deborah M Stephens, Nirav N Shah, Vaishalee P Kenkre, Stefan K Barta, Pallawi Torka, Geoffrey Shouse, Reem Karmali
Peri-CAR-T practice patterns and survival predictors for all CAR-T patients and post-CAR-T failure in aggressive B-NHL. Blood advances (2022)
Victor Manuel Orellana-Noia, Daniel R Reed, Ashley Alesia McCook, Jeremy Michael Sen, Christian M Barlow, Mary-Kate Malecek, Marcus P Watkins, Brad S Kahl, Michael A Spinner, Ranjana Advani, Timothy J Voorhees, Anson Snow, Natalie Sophia Grover, Amy A Ayers, Jason T Romancik, Yuxin Liu, Scott F Huntington, Julio C Chavez, Hayder Saeed, Aleksander Lazaryan, Vikram Raghunathan, Stephen E Spurgeon, Thomas A Ollila, Christopher Del Prete, Adam Olszewski, Emily C Ayers, Daniel J Landsburg, Benjamin Echalier, Jun Lee, Manali Kamdar, Paolo F Caimi, Timothy Fu, Jieqi Liu, Kevin A David, Hanan Alharthy, Jennie Y Law, Reem Karmali, Harsh R Shah, Deborah M Stephens, Ajay Major, Alexandra E Rojek, Sonali M Smith, Amulya Yellala, Avyakta Kallam, Shazia Nakhoda, Nadia Khan, Mohammad Ahsan Sohail, Brain T Hill, Odeth Barrett-Campbell, Frederick Lansigan, Jeffrey M Switchenko, Jonathon B Cohen, Craig A Portell
Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions. Blood (2021)